Warning Letter to Yiling Pharmaceutical Ltd.
Drugs. See Yiling Pharmaceutical's company page or this site's inspections.
On Mar 27, 2025, FDA's CDER sent Yiling Pharmaceutical Ltd. a warning letter citing cleaning validation, out-of-specification, quality unit; it is not closed out.
- Letter date: Mar 27, 2025
- Issued by: CDER
- Closeout: None yet
As posted on FDA.gov ↗; cited 21 CFR sections link to their page.
FDA's site did not return the letter just now. Read it on FDA.gov ↗
- Silgan Dispensing SystemsOct 5, 2026 · CDER · Sterility assurance, Cleaning validation
- Signature Formulations LLCOct 1, 2026 · CDER · Cleaning validation, Quality unit
- Baxter International Inc.Sep 29, 2026 · CDER · Aseptic processing, Sterility assurance
- Bentley Laboratories LLCSep 17, 2026 · CDER · Cleaning validation, Process validation
- TCI Co., Ltd BioCosme PABP BRANCHSep 2, 2026 · CDER · Cleaning validation, Process validation
- Recipient
- Mr. Hongzhi Li
- FDA site ID (FEI)
- 3011640199
- Cited
Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters